Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Immunological pathomechanisms in vitiligo.

E H Kemp¹, E A Waterman, A P Weetman

¹Division of Clinical Sciences, Northern General Hospital, University of Sheffield, Sheffield, S5 7AU, UK. e.h.kemp@sheffield.ac.uk

Expert Reviews in Molecular Medicine

|October 31, 2003

Summary

Vitiligo, a skin depigmentation disorder, may involve autoimmune responses. Research indicates the presence of autoantibodies and T cells targeting pigment cells in vitiligo patients, suggesting immune system involvement in disease development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An update on the pathogenesis of Hashimoto's thyroiditis.

Journal of endocrinological investigation·2020

Same author

Alemtuzumab-induced halo naevus-like hypopigmentation - new insights into secondary skin autoimmunity in response to an immune cell-depleting antibody.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

Same author

Association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and susceptibility to systemic lupus erythematosus in an Indian population.

Scandinavian journal of rheumatology·2015

Same author

Tumour necrosis factor-α antagonists as therapies for vitiligo.

The British journal of dermatology·2015

Same author

The Pathogenesis of Hashimoto's Thyroiditis: Further Developments in our Understanding.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2015

Same author

The CC genotype of the ERCC1 C118T single-nucleotide polymorphism impacts positively on the efficacy of narrowband ultraviolet B therapy for vitiligo.

The British journal of dermatology·2015

Area of Science:

Immunology
Dermatology
Autoimmunity

Background:

Vitiligo is a depigmenting skin disorder involving melanocyte loss.
Its exact cause is unknown, but immune system abnormalities are frequently observed.

Purpose of the Study:

To review and discuss the evidence supporting immunological pathomechanisms in vitiligo pathogenesis.
To explore the autoimmune component of vitiligo.

Main Methods:

Review of existing literature on vitiligo and immune responses.
Analysis of studies detecting autoantibodies and autoreactive T cells in vitiligo patients.
Examination of associations between vitiligo and other autoimmune diseases.

Main Results:

Related Experiment Videos

Circulating autoantibodies and autoreactive T cells targeting pigment cell antigens are detected in vitiligo patients.

Vitiligo frequently co-occurs with autoimmune conditions like Hashimoto's thyroiditis and type 1 diabetes.

Successful treatment with immunosuppressive therapies supports an immune role.

Conclusions:

Evidence strongly suggests that immune reactions play a significant role in the pathogenesis of vitiligo.
Vitiligo may have an autoimmune component, driven by immune responses against melanocytes.